We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+0.99%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$840M
AUM Growth
+$31M
(+3.8%)
Cap. Flow
+$28.6M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
47.07%
Holding
609
New
50
Increased
216
Reduced
106
Closed
43
Avg Time Held
1.9
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$19M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$3.69M |
| 3 |
Marathon Petroleum
MPC
|
+$3.68M |
| 4 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$3.2M |
| 5 |
Evergy
EVRG
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$17.4M |
| 2 |
3M
MMM
|
+$3.23M |
| 3 |
COL
Rockwell Collins
COL
|
+$3.13M |
| 4 |
Mondelez International
MDLZ
|
+$3.02M |
| 5 |
GXP
Great Plains Energy Incorporated
GXP
|
+$2.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.09% |
| 2 | Financials | 5.61% |
| 3 | Technology | 5.28% |
| 4 | Consumer Discretionary | 4.33% |
| 5 | Healthcare | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Pfizer
PFE
$168B
| $1.35M | 0.16% |
39,175
+2,296
| +6% | +$78.5K |
2013 Q2
20 quarters
|
|
102
Boston Scientific
BSX
$64B
| $1.34M | 0.16% |
40,957
-76
| -0.2% | -$2.29K |
2017 Q4
2 quarters
|
|
103
RTX Corp
RTX
$252B
| $1.34M | 0.16% |
16,988
+135
| +0.8% | +$10.6K |
2013 Q2
20 quarters
|
|
104
Amazon
AMZN
$2.75T
| $1.32M | 0.16% |
15,560
+2,140
| +16% | +$170K |
2017 Q2
4 quarters
|
|
105
PayPal
PYPL
$48.9B
| $1.32M | 0.16% |
15,804
-4,816
| -23% | -$384K |
2017 Q1
5 quarters
|
|
106
HP
HPQ
$27.8B
| $1.29M | 0.15% |
57,009
+661
| +1% | +$14.7K |
2017 Q3
3 quarters
|
|
107
Diamondback Energy
FANG
$54.8B
| $1.28M | 0.15% |
9,733
+69
| +0.7% | +$8.56K |
2016 Q3
7 quarters
|
|
108
DELISTED
Warner Bros
WBD
| $1.27M | 0.15% |
+46,098
| New | +$1.1M |
2018 Q2
0 quarters
|
|
|
ATVI
109
DELISTED
Activision Blizzard
ATVI
| $1.27M | 0.15% |
16,615
+129
| +0.8% | +$9.13K |
2014 Q2
16 quarters
|
|
110
Accenture
ACN
$138B
| $1.26M | 0.15% |
7,714
+58
| +0.8% | +$9.02K |
2013 Q2
20 quarters
|
|
111
Exelon
EXC
$43.8B
| $1.26M | 0.15% |
41,495
+688
| +2% | +$19.7K |
2017 Q2
4 quarters
|
|
112
AbbVie
ABBV
$501B
| $1.25M | 0.15% |
13,549
+174
| +1% | +$17K |
2013 Q3
19 quarters
|
|
113
CVS Health
CVS
$118B
| $1.25M | 0.15% |
19,490
+18,319
| +1,564% | +$1.21M |
2013 Q2
20 quarters
|
|
114
Meta Platforms (Facebook)
META
$1.88T
| $1.24M | 0.15% |
6,396
-39
| -0.6% | -$7.05K |
2013 Q2
20 quarters
|
|
115
Truist Financial
TFC
$56.9B
| $1.24M | 0.15% |
24,618
+87
| +0.4% | +$4.62K |
2017 Q2
4 quarters
|
|
116
Altria Group
MO
$123B
| $1.24M | 0.15% |
21,811
+4,420
| +25% | +$255K |
2013 Q2
20 quarters
|
|
117
DELISTED
Synovus
SNV
| $1.23M | 0.15% |
23,218
-110
| -0.5% | -$5.85K |
2015 Q3
11 quarters
|
|
118
Thermo Fisher Scientific
TMO
$258B
| $1.21M | 0.14% |
5,824
-35
| -0.6% | -$7.43K |
2015 Q4
10 quarters
|
|
119
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $1.21M | 0.14% |
4,446
+5
| +0.1% | +$1.35K |
2016 Q3
7 quarters
|
|
120
SAP
SAP
$260B
| $1.2M | 0.14% |
10,410
+202
| +2% | +$22.8K |
2015 Q4
10 quarters
|
|
121
Paychex
PAYX
$39.4B
| $1.2M | 0.14% |
17,603
+359
| +2% | +$23.2K |
2015 Q3
11 quarters
|
|
122
Boeing
BA
$149B
| $1.18M | 0.14% |
3,528
-1,575
| -31% | -$542K |
2017 Q3
3 quarters
|
|
123
Vanguard High Dividend Yield ETF
VYM
$81.4B
| $1.18M | 0.14% |
14,225
+271
| +2% | +$22.7K |
2013 Q2
20 quarters
|
|
124
FMC
FMC
$874M
| $1.18M | 0.14% |
+15,229
| New | +$1.13M |
2018 Q2
0 quarters
|
|
125
Cognizant
CTSH
$29.6B
| $1.18M | 0.14% |
14,887
+299
| +2% | +$23.5K |
2018 Q1
1 quarter
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q2 2018 Portfolio in Review
As of Q2 2018, Capital Analysts LLC held 609 positions worth $840M, up 3.8% from $809M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Capital Analysts LLC deployed $28.6M of net new capital in Q2 2018, opening 50 new positions and adding to 216 existing holdings. Its largest new stake was Vanguard Short-Term Inflation-Protected Securities Index Fund: 387,782 shares worth $18.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, up from 68% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $17.4M trimmed.
- Capital Analysts LLC's largest Q2 2018 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 387,782 shares worth $18.9M.
- Capital Analysts LLC added most to Carnival Corporation Ltd in Q2 2018, an estimated $3.69M increase.
- Capital Analysts LLC's biggest Q2 2018 reduction was iShares TIPS Bond ETF, cutting an estimated $17.4M.
- Capital Analysts LLC fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $2.93M.
- Capital Analysts LLC's ten largest holdings make up 47% of its $840M portfolio in Q2 2018.
- Capital Analysts LLC opened 50 new positions and closed 43 in Q2 2018.
- Capital Analysts LLC's portfolio value rose 3.8% quarter-over-quarter to $840M.
Based on Capital Analysts LLC's 13F filing for Q2 2018, filed 3 Aug 2018.